Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$86
+$38 QoQ
Shares Held
13
+225.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $117,796,291 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
228,025 | $49,593,157 | |
| 2 | LLY |
ELI LILLY & Co
|
27,501 | $25,294,594 | |
| 3 | JNJ |
Johnson & Johnson
|
79,700 | $19,481,868 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,030 | $4,815,208 | |
| 5 | PFE |
Pfizer Inc
|
143,430 | $4,027,514 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,884 | $3,328,713 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,185 | $3,165,020 | |
| 8 | AMGN |
Amgen Inc
|
8,658 | $3,046,317 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $86 | 13 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48 | 4 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $78 | 4 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $47 | 8 | Shares | Sole | 2025-07-28 | |
| No filing history on record for this holder in this stock. | ||||||